Dr. Henrique Bittencourt, MD PhD

Claim this profile

CHU Sainte-Justine Hematology-Oncology Division

Studies Leukemia
Studies Acute Lymphoblastic Leukemia
2 reported clinical trials
12 drugs studied

Clinical Trials Henrique Bittencourt, MD PhD is currently running

More about Henrique Bittencourt, MD PhD

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Henrique Bittencourt, MD PhD has experience with
  • ATG Thymoglobulin
  • Busulfan
  • Cyclophosphamide
  • Fludarabine
  • Grafalon
  • TBI

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Henrique Bittencourt, MD PhD specialize in?
Henrique Bittencourt, MD PhD focuses on Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Henrique Bittencourt, MD PhD currently recruiting for clinical trials?
Yes, Henrique Bittencourt, MD PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Henrique Bittencourt, MD PhD has studied deeply?
Yes, Henrique Bittencourt, MD PhD has studied treatments such as ATG Thymoglobulin, Busulfan, Cyclophosphamide.
What is the best way to schedule an appointment with Henrique Bittencourt, MD PhD?
Apply for one of the trials that Henrique Bittencourt, MD PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.